Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof

TW202629264APending Publication Date: 2026-07-16IMMUNOGEN INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
IMMUNOGEN INC
Filing Date
2018-02-27
Publication Date
2026-07-16
Patent Text Reader

Abstract

The invention relates to novel cell-binding agent-maytansinoid conjugate having a self-immolative peptide linker and more specifically to conjugates of formula (I). The invention also provides novel maytansinoid compounds of formula (II), (III), (IV) or (V). The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.
Need to check novelty before this filing date? Find Prior Art